{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:31:38Z","timestamp":1764603098750},"reference-count":75,"publisher":"Elsevier","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1016\/b978-0-12-391860-4.00014-8","type":"book-chapter","created":{"date-parts":[[2012,3,24]],"date-time":"2012-03-24T11:40:35Z","timestamp":1332589235000},"page":"271-294","source":"Crossref","is-referenced-by-count":29,"title":["Nanotechnology as a Promising Strategy for Alternative Routes of Insulin Delivery"],"prefix":"10.1016","author":[{"given":"Catarina Pinto","family":"Reis","sequence":"first","affiliation":[]},{"given":"Christiane","family":"Damg\u00e9","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0005","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/(SICI)1097-4636(19991215)47:4<568::AID-JBM14>3.0.CO;2-X","article-title":"Study of the mechanism of insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization","volume":"47","author":"Aboubakar","year":"1999","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1768-322X.1987.tb00571.x","article-title":"Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine","volume":"61","author":"Aprahamian","year":"1987","journal-title":"Biol. Cell"},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1023\/A:1015930821648","article-title":"Site dependence of absorption-promoting actions of laureth-9, Na salicylate, Na2EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery","volume":"5","author":"Aungst","year":"1988","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00404796","article-title":"Morphocytochemical and biochemical evidence for insulin absorption by the rat ileal epithelium","volume":"33","author":"Bendayan","year":"1990","journal-title":"Diabetologia"},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0025","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11095-007-9257-9","article-title":"Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin","volume":"24","author":"Bhumkar","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0030","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1166\/jbn.2009.036","article-title":"Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery","volume":"5","author":"Bi","year":"2009","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0035","series-title":"Protein Delivery: Physical Systems","first-page":"343","article-title":"Insulin formulation and delivery","author":"Brange","year":"1997"},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0168-3659(99)00247-3","article-title":"Nanosphere based oral insulin delivery","volume":"65","author":"Carino","year":"2000","journal-title":"J. Control. Rel."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2337\/diacare.27.1.239","article-title":"Concept, strategies, and feasibility of noninvasive insulin delivery","volume":"27","author":"Cefalu","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0050","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.clinthera.2005.10.007","article-title":"Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: A single-center, randomized, single-blind, 5-way crossover study","volume":"27","author":"Cernea","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0055","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2006.12.003","article-title":"A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin","volume":"117","author":"Chalasani","year":"2007","journal-title":"J. Control. Rel."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0060","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nbt1193","article-title":"Transdermal protein delivery by a coadministered peptide identified via phage display","volume":"24","author":"Chen","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0065","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1081\/DDC-120030930","article-title":"Insulin-loaded calcium pectinate nanoparticles: Effects of pectin molecular weight and formulation pH","volume":"30","author":"Cheng","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0070","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/02652049409040461","article-title":"Liposomes as a carrier for oral administration of insulin: Effect of formulation factors","volume":"11","author":"Choudhari","year":"1994","journal-title":"J. Microencapsul."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0075","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0378-5173(02)00175-8","article-title":"Absorption and efficiency of insulin after oral administration of insulin-loaded nanocapsules in diabetic rats","volume":"242","author":"Cournarie","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0080","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jconrel.2006.05.013","article-title":"Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation","volume":"114","author":"Cui","year":"2006","journal-title":"J. Control. Rel."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0085","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jps.20750","article-title":"Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery","volume":"96","author":"Cui","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0090","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2337\/diabetes.37.2.246","article-title":"New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier","volume":"37","author":"Damg\u00e9","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0168-3659(90)90013-J","article-title":"Nanocapsules as carriers for oral peptide delivery","volume":"13","author":"Damg\u00e9","year":"1990","journal-title":"J. Control. Rel."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0100","first-page":"3","article-title":"Effects of orally administered insulin nanocapsules in normal and diabetic dogs","volume":"8","author":"Damg\u00e9","year":"1995","journal-title":"Diab. Nutr. Metab."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0105","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1021\/js970124i","article-title":"Poly(alkylcyanoacrylate) nanospheres for oral administration of insulin","volume":"86","author":"Damg\u00e9","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0110","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1211\/0022357001774967","article-title":"Ileal uptake of polyalkyl-cyanoacrylate nanocapsules in the rat","volume":"52","author":"Damg\u00e9","year":"2000","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2006.10.023","article-title":"Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats","volume":"117","author":"Damg\u00e9","year":"2007","journal-title":"J. Control. Rel."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425247.5.1.45","article-title":"Nanoparticle strategies for the oral delivery of insulin","volume":"5","author":"Damg\u00e9","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0125","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/jps.21874","article-title":"Poly(epsilon-caprolactone)\/Eudragit nanoparticles for oral delivery of Aspart-insulin in the treatment of diabetes","volume":"99","author":"Damg\u00e9","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0130","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/BF00400466","article-title":"Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man","volume":"37","author":"Del Prato","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/10010065","article-title":"Polymeric nanoparticulates to improve oral bioavailability of peptide drugs","volume":"10","author":"Delie","year":"2005","journal-title":"Molecules"},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0140","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1023\/A:1016418523014","article-title":"Nasal delivery of insulin using novel chitosan based formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles","volume":"19","author":"Dyer","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0145","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1023\/A:1018908705446","article-title":"Enhancement of nasal absorption of insulin using chitosan nanoparticles","volume":"16","author":"Fern\u00e1ndez-Urrusuno","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0150","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1021\/bm9001377","article-title":"Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules","volume":"10","author":"Goycoolea","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0155","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejps.2005.04.009","article-title":"Microencapsulated chitosan nanoparticles for lung protein delivery","volume":"25","author":"Grenha","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/107175400266687","article-title":"Transdermal delivery of insulin in mice by using lecithin vesicles as a carrier","volume":"7","author":"Guo","year":"2000","journal-title":"Drug Deliv."},{"issue":"Suppl. 170","key":"10.1016\/B978-0-12-391860-4.00014-8_bb0165","first-page":"31","article-title":"New ways of insulin delivery","volume":"65","author":"Heinemann","year":"2010","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0170","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/dia.2006.8.369","article-title":"Transdermal delivery of CaCO3-nanoparticles containing insulin","volume":"8","author":"Higaki","year":"2006","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0175","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1248\/cpb.29.810","article-title":"New mucosal dosage form of insulin","volume":"29","author":"Ishida","year":"1981","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1463-1326.2009.01150.x","article-title":"Oral insulin\u2014A review of current status","volume":"12","author":"Iyer","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0185","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ejpb.2007.12.001","article-title":"Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier","volume":"69","author":"Jain","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0168-3659(98)00184-9","article-title":"Transdermal iontophoretic delivery of bovine insulin and monomeric human insulin analogue","volume":"59","author":"Kanikkannan","year":"1999","journal-title":"J. Control. Rel."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0195","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/bm0607776","article-title":"Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery","volume":"8","author":"Lin","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0200","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijpharm.2008.01.008","article-title":"Solid lipid nanoparticles for pulmonary delivery of insulin","volume":"356","author":"Liu","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0205","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijpharm.2004.12.025","article-title":"Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats","volume":"293","author":"Ma","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0210","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1007\/s11095-005-8175-y","article-title":"Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells","volume":"22","author":"Mao","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0215","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijpharm.2004.10.003","article-title":"Oral and subcutaneous absorption of insulin poly(isobutylcyanoacrylate) nanoparticles","volume":"288","author":"Mesiha","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0220","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1002\/dmrr.208","article-title":"The evolving role of oral insulin in the treatment of diabetes using a Rapid Mist\u2122 system","volume":"18","author":"Modi","year":"2002","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0225","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijpharm.2003.07.015","article-title":"Calcium phosphate-PEG-insulin-casein (CAPIC) particles as oral delivery systems for insulin","volume":"277","author":"Mor\u00e7ol","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0230","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0169-409X(98)00037-4","article-title":"The effect of physical barriers and properties on the oral absorption of particulates","volume":"34","author":"Norris","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0235","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1046\/j.1464-5491.2003.01076.x","article-title":"Alternative routes of insulin delivery","volume":"20","author":"Owens","year":"2003","journal-title":"Diabet. Med."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(02)00486-6","article-title":"Bioadhesive polysaccharide in protein delivery system: Chitosan nanoparticles improve the intestinal absorption of insulin in vivo","volume":"249","author":"Pan","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0245","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejps.2006.04.014","article-title":"Nanoscale analysis of protein and peptide absorption: Insulin absorption using complexation and pH-sensitive hydrogels as delivery vehicles","volume":"29","author":"Peppas","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nano.2006.04.009","article-title":"Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems","volume":"2","author":"Pinto Reis","year":"2006","journal-title":"Nanomedicine"},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0255","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nano.2005.12.003","article-title":"Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles","volume":"2","author":"Pinto Reis","year":"2006","journal-title":"Nanomedicine"},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0260","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejps.2006.12.007","article-title":"Nanoparticulate delivery system for insulin: Design, characterization and in vitro\/in vivo bioactivity","volume":"30","author":"Pinto Reis","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0265","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1023\/A:1024470508758","article-title":"Visualization of insulin-loaded nanocapsules: In vitro and in vivo studies after oral administration to rats","volume":"20","author":"Pinto-Alphandary","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0270","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1021\/bm060065f","article-title":"Chitosan graft copolymer nanoparticles for oral protein drug delivery: Preparation and characterization","volume":"7","author":"Qian","year":"2006","journal-title":"Biomacromolecules"},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0275","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1081\/DDC-100107680","article-title":"Enhancement of absorption of insulin-loaded polyisobutylcyanoacrylate nanospheres by sodium cholate after oral and subcutaneous administration in diabetic rats","volume":"27","author":"Radwan","year":"2001","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0280","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/02652040110081406","article-title":"The effect of oral absorption enhancers on the in vivo performance of insulin-loaded poly(ethylcyanoacrylate) nanospheres in diabetic rats","volume":"19","author":"Radwan","year":"2002","journal-title":"J. Microencapsul."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0290","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/10717540801905165","article-title":"Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery","volume":"15","author":"Reis","year":"2008","journal-title":"Drug Deliv."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0295","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1002\/jps.21347","article-title":"Nanoparticulate biopolymers deliver insulin orally","volume":"97","author":"Reis","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0300","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1006\/jaut.1996.0093","article-title":"Prophilactic oral administration of metabolically active insulin entrapped in isobutylcyanoacrylate nanocapsules reduces incidence of diabetes in non obese diabetic mice","volume":"9","author":"Sai","year":"1996","journal-title":"J. Autoimmun."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0305","first-page":"299","article-title":"Novel pH responsive polymethacrylic acid-Chitosan-polyethylene glycol nanoparticles for oral peptide delivery","volume":"76","author":"Sajeesh","year":"2005","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0310","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijpharm.2006.06.019","article-title":"Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery","volume":"325","author":"Sajeesh","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0315","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.colsurfb.2006.09.012","article-title":"Development and characterization of new insulin containing polysaccharide nanoparticles","volume":"53","author":"Sarmento","year":"2006","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0320","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1007\/s11095-007-9367-4","article-title":"Alginate\/chitosan nanoparticles are effective for oral insulin delivery","volume":"24","author":"Sarmento","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0325","first-page":"743","article-title":"Oral insulin delivery by means of solid lipid nanoparticles","volume":"2","author":"Sarmento","year":"2007","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0330","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s11095-005-7676-z","article-title":"Insulin containing nanocomplexes formed by self-assembly from biodegradable amine-modified poly(vinyl alcohol)-graft-poly(l-lactide): Bioavailability and nasal yolerability in rats","volume":"22","author":"Simon","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(00)00339-4","article-title":"Biodegradable polymeric nanoparticles as drug delivery devices","volume":"70","author":"Soppimath","year":"2001","journal-title":"J. Control. Rel."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0340","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/193229681000400314","article-title":"Comparison pharmacokinetics of two concentrations (0.7% and 1.0%) of Nasulin, an ultra-rapid-acting intranasal insulin formulation","volume":"4","author":"Stote","year":"2010","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0345","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1023\/A:1011908128045","article-title":"Recent advances in intestinal macromolecular drug delivery via receptor-mediated transport pathways","volume":"15","author":"Swaan","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0350","first-page":"217","article-title":"Pelleted bioadhesive polymeric nanoparticles for buccal delivery of insulin: Preparation and characterization","volume":"56","author":"Venugopalan","year":"2001","journal-title":"Pharmazie"},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0355","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0939-6411(00)00144-2","article-title":"Factors and strategies for improving buccal absorption of peptides","volume":"51","author":"Veuillez","year":"2001","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0360","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1043661802002049","article-title":"Hypoglycaemic effect of a novel insulin buccal formulation on rabbits","volume":"46","author":"Xu","year":"2002","journal-title":"Pharmacol. Res."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0365","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1248\/cpb.58.1195","article-title":"Preparation of gel-core-solid lipid nanoparticle: A novel way to improve the encapsulation of protein and peptide","volume":"58","author":"Yang","year":"2010","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0370","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5173(01)00614-7","article-title":"Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats","volume":"218","author":"Zhang","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0375","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1166\/jnn.2006.425","article-title":"Transport characteristics of wheat germ agglutinin-modified insulin-liposomes and solid lipid nanoparticles in a perfused rat intestinal model","volume":"6","author":"Zhang","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/B978-0-12-391860-4.00014-8_bb0380","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1080\/03639040902769628","article-title":"The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery","volume":"35","author":"Zhang","year":"2009","journal-title":"Drug Dev. Ind. Pharm."}],"container-title":["Methods in Enzymology","Nanomedicine - Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary and Inflammatory Diseases"],"original-title":[],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T19:22:41Z","timestamp":1543087361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780123918604000148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":75,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-391860-4.00014-8","relation":{},"ISSN":["0076-6879"],"issn-type":[{"value":"0076-6879","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}